Literature DB >> 25266720

MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor α: implications for cancer therapeutics.

Ankana Tiwari1, Swamy Shivananda2, Kodaganur S Gopinath2, Arun Kumar3.   

Abstract

Estrogen-related receptor α (ESRRA) functions as a transcription factor and regulates the expression of several genes, such as WNT11 and OPN. Up-regulation of ESRRA has been reported in several cancers. However, the mechanism underlying its up-regulation is unclear. Furthermore, the reports regarding the role and regulation of ESRRA in oral squamous cell carcinoma (OSCC) are completely lacking. Here, we show that tumor suppressor miR-125a directly binds to the 3'UTR of ESRRA and represses its expression. Overexpression of miR-125a in OSCC cells drastically reduced the level of ESRRA, decreased cell proliferation, and increased apoptosis. Conversely, the delivery of an miR-125a inhibitor to these cells drastically increased the level of ESRRA, increased cell proliferation, and decreased apoptosis. miR-125a-mediated down-regulation of ESRRA impaired anchorage-independent colony formation and invasion of OSCC cells. Reduced cell proliferation and increased apoptosis of OSCC cells were dependent on the presence of the 3'UTR in ESRRA. The delivery of an miR-125a mimic to OSCC cells resulted in marked regression of xenografts in nude mice, whereas the delivery of an miR-125a inhibitor to OSCC cells resulted in a significant increase of xenografts and abrogated the tumor suppressor function of miR-125a. We observed an inverse correlation between the expression levels of miR-125a and ESRRA in OSCC samples. In summary, up-regulation of ESRRA due to down-regulation of miR-125a is not only a novel mechanism for its up-regulation in OSCC, but decreasing the level of ESRRA by using a synthetic miR-125a mimic may have an important role in therapeutic intervention of OSCC and other cancers.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cancer Biology; Cell Proliferation; Head and Neck Squamous Cell Carcinoma; MicroRNA (miRNA); Post-transcriptional Regulation

Mesh:

Substances:

Year:  2014        PMID: 25266720      PMCID: PMC4231701          DOI: 10.1074/jbc.M114.584136

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growth.

Authors:  Kurt W Fisher; Binita Das; Robert L Kortum; Oleg V Chaika; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

2.  Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.

Authors:  Gary K Scott; Andrei Goga; Dipa Bhaumik; Crystal E Berger; Christopher S Sullivan; Christopher C Benz
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

3.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

Review 4.  Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.

Authors:  Geneviève Deblois; Vincent Giguère
Journal:  Nat Rev Cancer       Date:  2012-11-29       Impact factor: 60.716

5.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

6.  miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia.

Authors:  Melanie L Ufkin; Sarah Peterson; Xuehui Yang; Heather Driscoll; Christine Duarte; Pradeep Sathyanarayana
Journal:  Leuk Res       Date:  2014-01-08       Impact factor: 3.156

7.  MicroRNA-125a represses cell growth by targeting HuR in breast cancer.

Authors:  Xu Guo; Yuehan Wu; Rebecca S Hartley
Journal:  RNA Biol       Date:  2009 Nov-Dec       Impact factor: 4.652

8.  Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

Authors:  Takashi Suzuki; Yasuhiro Miki; Takuya Moriya; Norihiro Shimada; Takanori Ishida; Hisashi Hirakawa; Noriaki Ohuchi; Hironobu Sasano
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

9.  ERRα metabolic nuclear receptor controls growth of colon cancer cells.

Authors:  Gérald Bernatchez; Véronique Giroux; Thomas Lassalle; André C Carpentier; Nathalie Rivard; Julie C Carrier
Journal:  Carcinogenesis       Date:  2013-05-29       Impact factor: 4.944

10.  Estrogen-related receptor alpha (ERRalpha) inverse agonist XCT-790 induces cell death in chemotherapeutic resistant cancer cells.

Authors:  Feng Wu; Junjian Wang; Yanfei Wang; Tim-Tak Kwok; Siu-Kai Kong; Chiwai Wong
Journal:  Chem Biol Interact       Date:  2009-05-21       Impact factor: 5.192

View more
  22 in total

Review 1.  Comparative analysis of gene expression profiles of OPN signaling pathway in four kinds of liver diseases.

Authors:  Gaiping Wang; Shasha Chen; Congcong Zhao; Xiaofang Li; Weiming Zhao; Jing Yang; Cuifang Chang; Cunshuan Xu
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

2.  Diagnostic and prognostic relevance of salivary microRNA-21, -125a, -31 and -200a levels in patients with oral lichen planus - a short report.

Authors:  Masoumeh Mehdipour; Minoo Shahidi; Soheila Manifar; Soudeh Jafari; Fatemeh Mashhadi Abbas; Mahmood Barati; Hamed Mortazavi; Mohammad Shirkhoda; Amir Farzanegan; Zahra Elmi Rankohi
Journal:  Cell Oncol (Dordr)       Date:  2018-02-26       Impact factor: 6.730

Review 3.  MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.

Authors:  Min Cao; Lijuan Zheng; Jianzhou Liu; Thomas Dobleman; Shen Hu; Vay Liang W Go; Ge Gao; Gary Guishan Xiao
Journal:  Clin Oral Investig       Date:  2018-01-03       Impact factor: 3.573

4.  MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2.

Authors:  Zhong-Liang Ma; Pin-Pin Hou; Yan-Li Li; De-Tao Wang; Tian-Wei Yuan; Jia-Li Wei; Bo-Tao Zhao; Jia-Tao Lou; Xin-Tai Zhao; Yan Jin; You-Xin Jin
Journal:  Tumour Biol       Date:  2014-12-13

5.  High expression of estrogen-related receptor α is significantly associated with poor prognosis in patients with colorectal cancer.

Authors:  Rong Liang; Yan Lin; Chun-Ling Yuan; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Hai-Hong Ye
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

Review 6.  Small molecules targeting microRNA for cancer therapy: Promises and obstacles.

Authors:  Di Wen; Michael Danquah; Amit Kumar Chaudhary; Ram I Mahato
Journal:  J Control Release       Date:  2015-08-06       Impact factor: 9.776

7.  ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer.

Authors:  Subrata Manna; Josefine Bostner; Yang Sun; Lance D Miller; Anya Alayev; Naomi S Schwartz; Elin Lager; Tommy Fornander; Bo Nordenskjöld; Jane J Yu; Olle Stål; Marina K Holz
Journal:  Clin Cancer Res       Date:  2015-11-05       Impact factor: 12.531

8.  RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.

Authors:  Scott M Riester; Diren Arsoy; Emily T Camilleri; Amel Dudakovic; Christopher R Paradise; Jared M Evans; Jorge Torres-Mora; Marco Rizzo; Peter Kloen; Marianna Kruithof-de Julio; Andre J van Wijnen; Sanjeev Kakar
Journal:  BMC Med Genomics       Date:  2015-10-07       Impact factor: 3.063

9.  Intranasal Administration of Lentiviral miR-135a Regulates Mast Cell and Allergen-Induced Inflammation by Targeting GATA-3.

Authors:  Yu-Qin Deng; Ya-Qi Yang; Shui-Bin Wang; Fen Li; Meng-Zhi Liu; Qing-Quan Hua; Ze-Zhang Tao
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

10.  miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.

Authors:  Violaine Tribollet; Bruno Barenton; Auriane Kroiss; Séverine Vincent; Ling Zhang; Christelle Forcet; Catherine Cerutti; Séverine Périan; Nathalie Allioli; Jacques Samarut; Jean-Marc Vanacker
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.